Augenzentrum Bergisch Gladbach und Bensberg provides ophthalmological services including individual prevention, LASIK, cataract surgery, and more. Self-described as a practice with modern facilities and quality management.

Augenzentrum Bergisch Gladbach und Bensberg

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Alcon Inc.

Bausch Health develops, manufactures, and markets a range of pharmaceutical products and medical devices, self-described as enriching lives through a relentless drive to deliver better health outcomes.

Bausch Health

DORC is a supplier of equipment, instruments, and liquids for ophthalmic surgery, self-described as one of the world’s leading suppliers.

Metric
Company Name	Augenzentrum Bergisch Gladbach und Bensberg	Alcon Inc.	Bausch Health	DORC
Symbol		ALC
MSH ID	DE:AUGENZENTRUM-BERGISCHGLADBACH	COM:ALCON	COM:BAUSCHHEALTH	COM:DORCGLOBAL
Market	PRIVATE	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare & Health Services		Healthcare & Health Services	Healthcare & Health Services
Industry	Medical Services		Pharmaceuticals	Medical Devices
Country	DE	CH	CA	NL
Stage
Employee Count		25K
Website	augenzentrum-bergischgladbach.de	alcon.com	bauschhealth.com	dorcglobal.com
LinkedIn
Founders

Metric
Market Cap		37.60B
Enterprise Value
Monthly Web Traffic		293
Web Traffic Growth		-0.72
Valuation
Raised Capital

Metric
Revenue		9.46B
Revenue (LTM)
Revenue (NTM)
Gross Profit		5.25B
EBITDA		2.29B
Operating Income		1.04B
Net Income		974M
EPS		1.98
Diluted EPS		1.98
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.56
Operating Profit Margin		0.12
EBITDA Margin		0.24
Net Profit Margin		0.11
Return on Equity		0.10
Return on Assets		0.04
Return on Capital Employed		0.04

AUGE

DE:AUGENZENTRUM-BERGISCHGLADBACH

Augenzentrum Bergisch Gladbach und Bensberg

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		82.75
P/B Ratio		1.89
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		5.16
EV Multiple		36.34

Metric
Days Sales Outstanding		66.36
Days Payables Outstanding		75.78
Days Inventory Outstanding		201.41
Operating Cycle		282.86
Cash Conversion Cycle		212.52
Asset Turnover		0.32

Metric
Operating Cash Flow		1.39B
Free Cash Flow		537M
Cash Flow to Debt		0.36
Operating Cash Flow/Sales		0.19
Free Cash Flow Yield		0.01

Metric
Cash & Equivalents		1.09B
Accounts Receivable		-110M
Inventory		2.32B
Goodwill		8.93B
Debt to Capitalization		0.20
Debt to Assets		0.17
Current Ratio		1.87
Quick Ratio		1.56

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.01
R&D to Revenue		0.09
SG&A to Revenue